Mark Hiram Kaplan, M.D.

Lecturer, Internal Medicine/Infectious Diseases

**** *. ******* ****** *****, 5240 MSRB III

Ann Arbor, MI 48109-0640

734-***-****

abqio7@r.postjobfree.com

Education and Training

9/1958-6/1962 B.S., (with Honors) Chemistry, Cornell University, Ithaca, New York

7/1962-6/1966 M.D., Cornell University Medical College, New York, New York

7/1966-6/1967 Internship, Bellevue Hospital, Cornell Division, New York, New York

7/1967-6/1968 Residency, Bellevue Hospital, Cornell Division, New York, New York

7/1968-6/1970 Captain US Army, Fort Carson, Colorado

7/1970-6/1971 Chief Resident, Memorial Sloan-Kettering Cancer Center, New York, New York

7/1971-6/1973 Fellowship, Infectious Disease, Memorial Sloan-Kettering Cancer Center, New York, New York

Certification and Licensure

1972 Board Certification, Internal Medicine

1974 Board Certification, Infectious Disease

1967 New York State Medical License #100478 (active)

1968 New York State Controlled Substance License #AK0806894 (active)

2004 State of Michigan Medical License #430*******

2004 State of Michigan Pharmacy Controlled Substance License #531-***-****

Academic, Administrative, and Clinical Appointments

1973-1974 Assistant Professor of Medicine,

Cornell University Medical College, New York, New York

1973-1974 Assistant Attending Physician,

Infectious Disease Memorial Hospital, New York, New York

1974-1980 Assistant Professor of Medicine,

State University of New York, Stony Brook, New York

1974-1980 Chief, Infectious Disease & Attending Physician,

Nassau County Medical Center, East Meadow, New York

1978-1984 Adjunct Staff & Guest Investigator,

Rockefeller University, New York, New York

1980-1984 Assistant Professor of Medicine,

Cornell University Medical College, New York, New York

1980-1988 Adjunct Staff, Nassau County Medical Center, East Meadow, New York

1980-1994 Chief, Infectious Diseases & Attending Physician,

Department of Medicine, North Shore University Hospital, Manhasset, New York

1984-1993 Associate Professor of Medicine,

Cornell University Medical College, New York, New York

1993-1996 Professor of Clinical Medicine,

Cornell University Medical College, New York, New York

1994-2005 Director, Center for AIDS Research & Treatment

Department of Medicine, Division of Infectious Disease,

North Shore University Hospital, Manhasset, New York

1996-2001 Professor of Clinical Medicine

NYU School of Medicine, New York, New York

2001-2005 Jane & Dayton Brown Professor of Clinical Medicine,

NYU School of Medicine, New York, New York

2005-Present Lecturer Medicine- Department of Medicine, Division of Infectious Disease, University of Michigan, Ann Arbor MI

2005-present Attending Department of Medicine, Division of Infectious Disease University of Michigan, Ann Arbor, Michigan

Research Interests

-Human Retroviruses (HTLV-1, II, -HIV-1, -Deleted Proviruses,

-Hepatitis C virus infection and co-infection with HIV

-Herpes Virus VI, -Cytomegalovirus-pathogenesis

-Tuberculosis

-Kaposi’s sarcoma

-Search for new infectious agents in human disease,

-Clinical infectious disease

-Clinical problems in AIDS, Chronic Fatigue Syndrome

-Dermatologic manifestation of infectious disease

-HIV Prevention Education

-Search for Viruses of Human Lymphoma

-Biology of ELF3 gene in human breast cancer, Human Endogenous Retroviruses

Grants

Present and Active

Sponsor: Executive Board of Directors of Concerned Parents for AIDS Research (CPFA)

Title: A Search for a Viral Cause of HIV-Associated Lymphoma Hodgkin’s Diseases

PI: Mark H. Kaplan

Dates: 9/6/05-9/5/08

Funding Amount: $110,000/year

Sponsor: DPC-961-201 (Dupont Pharmaceuticals)

Title: A Randomized, Double-Blind Dose-Ranging Study to Assess the Safety and Tolerability of Three Doses of DPC-961 versus Efavirenz in Combination with Open-Label Zidovudine and Lamivudine In Antiretroviral Na ve HIV-1-Infected Patients

PI: Mark Kaplan

Dates: 1999-2003

Funding Amount: $10,000

Sponsor: Meadowbrook Medical Education & Research Foundation

Title: Funding for studies of serological reactions in patients with Tuberculosis.

PI: Mark Kaplan

Dates: 1978-1979

Funding Amount: NA

Sponsor: Meadowbrook Medical Evaluation & Research Foundation

Title: Funding for antigen retrieval in the study of Varicella Zoster Virus

PI: Mark Kaplan

Dates: 1979-1980

Funding Amount: NA

Sponsor: Heiser Foundation

Title: The study of antibody responses in Leprosy to myobacterial antigens

PI: Mark Kaplan

Dates: 1979-1980

Funding Amount: $10,000

Sponsor: Herman Goldman Foundation Award

Title: The new technology known as Enzyme Linked Immunosorbant Assay (ELISA)

PI: Mark Kaplan

Dates: 1982-1983

Funding Amount: $150,000 over 5 years

Sponsor: New York State Research Grant

Title: Factors influencing progression of HTLV-III infection. Continued prospective study in a suburban community

PI: Mark Kaplan

Dates: 1986-1988

Funding Amount: $20,000

Sponsor: AIDS Clinical Trial Grant (ACTG 175-177)

Title:

PI: Mark Kaplan-NSUH

Dates: 1992-1996

Role: Co-PI

Funding Amount: NA

Sponsor: Nassau-Suffolk Health Systems Agency (Ryan White/Federal Funding)

Title: HIV in Women

PI: Mark Kaplan

Dates: 1994-2000

Funding Amount: $100,000/year

Sponsor: HIV and Substance Abuse Counseling - Ryan White Title I

Title: Comprehensive AIDS Resources Emergency CareAct

PI: Mark Kaplan

Dates: 1996-2000

Funding Amount: $56,365/year

Sponsor: Title I Comprehensive AIDS Resources Emergency Care

Title: HIV and Reimbursable Mental Health Services - Ryan White

PI: Mark Kaplan

Dates: 1996-2000

Funding Amount: $46,397/year

Sponsor: Viracept 506. Agouron Pharmaceuticals Inc.

Title: A Phase II Randomized Double Blind, Placebo Controlled, dose Range-Finding Study of Viracept as Monotherapy in HIV Positive Patients

PI: Mark Kaplan

Dates: 1996-1998

Funding Amount: $180,000

Study 505. A Phase III Randomized Double Blind, Placebo controlled Study of VIRACEPT in Combination with stavudine (d4tT) Alone in HIV Positive Patients.

Sponsor: Immune Response Corporation-Study 816

Title: A Phase II Study to Evaluate the Combination of REMUNE-TM and Triple Antiviral Drug Therapy on HIV-2 Specific Immunogenicity in HIV-1 Infected Subjects with CD4 Counts

PI: Mark Kaplan

Dates: 1996-1998

Funding Amount: $60,000

Sponsor: DPC-961-201. Dupont Merck Pharmaceuticals Inc.

Title: A Phase III, Double Blind, Placebo-Controlled, Multicenter Study to Determine the Effectiveness and Tolerability of the Combination of DMP266 and Indinavir versus Indinavir in HIV Infected Patients receiving Nucleoside Analog (NRTI) Therapy

PI: Mark Kaplan

Dates: 1997-1998

Funding Amount: $80,000

Sponsor: GMS-CSF (Immunex)

Title: Placebo Controlled Trial of Recombinant Human Granulocyte Macrophage Colony Stimulating Factor In Patients with Advanced HIV Disease

PI: Mark Kaplan

Dates: 1997

Funding Amount: $30,000

Sponsor: Agouron Pharmaceuticals, Inc.

Title: A Phase II, Randomized Double-Blind, Placebo Controlled, Dose Range-Finding Study of Viracept as Monotherapy in HIV Positive Patients Study 505. A Phase III Randomized Double Blind, Placebo Controlled Study of VIRACEPT in Combination with Stavudine (d4tT) along in HIV Positive Patients

PI: Mark Kaplan

Dates: 1998-2000

Funding Amount: $180,000

Sponsor: Joyce Mertz-Gilmore Foundation

Title: Development of NASBA Technology for the Diagnosis and Management of Infectious Diseases

PI: Mark Kaplan

Dates: 1998-2000

Funding Amount: $200,000

Sponsor: Fortovase (Roche)

Title: A Randomized Phase IIIB Comparative Study to Evaluate Saquinavir Soft Gel Capsule (sgc) TID in Combination with Two NRTIs Versus Saquinavir Soft Gel Capsules (sgc) BID Regimen in Combination with Two NRTIs Versus Saquinavir Soft Gel Capsule (sgc) BID Plus Nelfinavir BID Plus a NRTI in HIV-1 Infected Patients

PI: Mark Kaplan

Dates: 1998

Funding Amount: $8,000

Sponsor: Hepatitis C (Schering Plough)

Title: A Multicenter, Randomized, Open-Label Study of Combined Ribavirin and 3 or 5 Million Units of Intron Alfa 2b in The Treatment of Chronic Hepatitis C Resistant to Interferon Alone

PI: Mark Kaplan

Dates: 1998

Funding Amount: $25,000

Sponsor: DMP-266-044 (DuPont Pharmaceuticals)

Title: A Phase II, Open Label, Multicenter Study to Characterize the Effectiveness and Safety, of Stavudine and Didanosine in Combination with Efavirenz in antiretroviral Therapy Na ve HIV-Infected Patients

PI: Mark Kaplan

Dates: 1998-1999

Funding Amount: $50,000

Sponsor: DMP 266-020 Dupont Merck

Title: A Phase III, Double-blind, Placebo Controlled, Multicenter Study to Determine the Effectiveness and Tolerability of the Combination of DMP 266 and Indinavir versus Indinavir in HIV Infected patients Receiving Nucleoside Analogue (NRTI) Therapy

PI: Mark Kaplan

Dates: 1998-1999

Funding Amount: $50,000

Sponsor: GMS-SF (Immunex)

Title: A Phase IV Randomized, Double-Blinded, Placebo Controlled Trial of Recombinant Human Granulocyte Macrophage Colony Stimulating Factor in Patients with Advanced HIV Disease

PI: Mark Kaplan

Dates: 1998-2000

Funding Amount: $10,000

Sponsor: NY State AIDS Institute Grant

Title: Adherence to Medication of HIV Infected Patients

PI: Mark Kaplan

Dates: 1998-2000

Funding Amount: $200,000/yr./3 years

Sponsor: Procrit (Ortho BioTech)

Title: The Effect of a Weekly Dosing Regimen of Procrit (Epoetin alfa) on the Quality of Live In the Treatment of Anemia in HIV-Infected Patients on Antiretroviral Therapy

PI: Mark Kaplan

Dates: 1998-2000

Funding Amount: $3,000

Sponsor: ABBOTT (Abbott Laboratories)

Title: A Randomized, Open-Label, Phase III Study of ABT 378/Ritonavir in Combination with Nevirapine and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) vs. Investigator Selected Protease Inhibitor In Combination with Nevirapine and Two NRTIS In Antiretroviral-Experienced HIV-Infected Subjects (Protocol M98-888)

PI: Mark Kaplan

Dates: 1999

Funding Amount: $5,000

Sponsor: ZEST QD-Trial

PI: Mark Kaplan

Dates: 2003

Funding Amount: $23,000

Honors and Awards

1974-1976 Teacher of the Year, Nassau County Medical Center

1980 Best Published Paper: William H. Rorer, Inc., Award in American Journal of Gastroenterology; Phycomycosis of the Gastrointestinal Tract

1999 Best Doctors in New York-New York Magazine, 1999Best Doctors in New York-New York Magazine, 2000Best Doctors in New York-New York Magazine, 2001Best Doctors in New York- New York Magazine 2002Best Doctors in New York- New York Magazine 2003

Memberships in Professional Societies

1973-1995 American Society for Microbiology

1978-present Fellow, American College of Physicians

1981-present Infectious Disease Society of America

1983-1995 Society of Hospital Epidemiologists of America

1983-2005 New York Academy of Sciences

1984-present American Society for the Advancement of Science

1985-present Fellowship, Infectious Disease Society

Editorial Positions, Boards, and Peer-Review Service

1999-present Institute of Human Virology, University Maryland

2003-2005 NY State AIDS Advisory Board

2003-present Board of Trustees Institute of Human Virology, University of Maryland

2003-2005 Scientific Advisor Biosyn Pharmaceuticals

2002- present Member Scientific Advisory Board, Institute of Human Virology, University of Maryland

Teaching

Weekly Infectious Disease/AIDS Clinic-2005

Daily AIDS Service Rounds-2005

Daily Infectious Disease Service Rounds-2005

Weekly Infectious Disease Conferences-2005

Medical Student Preceptor in Office Practice-2005

Participate in education of Fellows-2005

Teaching PA Course at Hofstra University-Infectious Disease-2005

Ward Attending University of Michigan-present

Committee, Organizational, and Volunteer Service

National & Regional:

1983-present Collaborator, Laboratory of Tumor Cell Biology,

(Robert C. Gallo, M.D.), National Cancer Institute, Bethesda, Maryland

1990-1995 Chairman, Prevention Committee, Nassau County AIDS Commission

1996-present Scientific Advisory Board/Institute of Human Virology,

University of Maryland, Baltimore, Maryland.

Hospital:

1980-2004 Director, Jane & Dayton T. Brown & Dayton Brown, Jr., Virology Laboratory, NSUH

1980-1985 Chairman, Environmental & Infection Control Committee, NSUH

1980-1998 Member, Transfusion Committee, NSUH

1980-1990 Director, Bacteriology Research Laboratory, NSUH

1990-2005 Member, Advisory Board, Region Home Care, NSUH

1994-2005 Quality Assurance Committee, Department of Medicine, NSUH

1996-2005 Ambulatory Health Committee, NSUH

Consulting Positions

Boards of Trustees

2003-present Board of Trustees, Institute of Human Virology, University of Maryland

Scientific Advisory BoardsChairman, Prevention Committee, HIV Commission, Nassau County Department of Health

1999-present Institute of Human Virology, University of Maryland

2003-2005 NY State AIDS Advisory Board

2003-2005 Biosyn Pharmaceuticals

PATENTS

PCT Patent Application N. PCT/US2003/037200 International Filing Date November 21, 2003.

Title: ELF3 Gene Compositions and Methods

Applicant: North Shore-Long Island Jewish Research Institute

Inventors/Applicants (US): Mark H. Kaplan, MD, Xue-Ping Wang and Michael H. Dosik

Bibliography

Peer-Reviewed Journals and PublicationsCash WD, Kaplan MH: A comparison of the effects of 8-lysine vasopressin on the blood glucose levels in rabbits. Endocrinology 74:803-804, 1964.

Wunderlich B, Bodily DM, Kaplan MH: Theory and measurements of the glass transformation interval of poly styrene. J.Appl Phys 35:95-102, 1964.

Meyer RD, Kaplan MH, Ong M. Armstrong D: Cutaneous lesions in disseminated mucomycosis JAMA 225:737-738,1973.

Kaplan MH, Singer C, Armstrong D: Giardia lamblia infection in travelers to the Soviet Union. MMWR 23:78-79, 1974.

Gerstein MJ, Hadden EM, Kaplan MH, Pinsky CM, Armstrong D, Hadden JW: Immunologic defects in melanoma patients’ Lack of effect of BCG therapy. Memorial Sloan-Kettering Cancer Center. Clinical Bulletin 7:63-68, 1977.

Kaplan MH, Bernstein LS: Improved therapy for Vietnam acquired Vivax Malaria. Military Medicine 139:444-448,1974.

Kaplan MH, Armstrong D, Rosen P: Tuberculosis complicating neoplastic disease: A review of 201 cases. Cancer 33:850-858, 1974.

Fanning WL, Gump DW, Kaplan MH: Vestibular reaction to minocycline follow-up. Georgia, New York & Vermont. MMWR 24:55, 1975.

Kaplan MH, Klwin SW, McPhee J, Lyman DO: Coxsackie virus outbreak- New York. MMWR 25:377, 1976.

Singer C, Kaplan MH, Armstrong D: Sepsis in patients with leukemias and lymphomas. Antibiotics & Chemotherapy 21: 187-188, 1976.

Singer C, Kaplan MH, Armstrong D: Bacteremia and fungemia complicating neoplastic disease: A study of 364 cases. Am J Med 62:731-742, 1977.

Kaplan MH, Rosen P, Armstrong D: Cryptococcosis in a cancer hospital. Clinical and pathological correlates in forty-six patients. Cancer 39:2265-2274, 1977.

Saigo P, Rosen PP, Kaplan MH, Solan G, Melamed MR: Identification of cryptococcus neoformans in cytologic preparations of cerebro-spinal fluid. Am J Clin Path 67:141-145, 1967.

Lyon DT, Schubert TT, Mantia AG, Kaplan MH: Phycomycosis of the gastrointestinal tract. Amer J Gastro 72:379-394, 1979.

Tejani N, Klein SW, Kaplan MH: Subclinical herpes simplex genitalis infections in the perinatal period. Amer J OB/gyn 135:547, 1979.

Kaplan MH, Chase MW: The dynamics of antibody responses to nine defined mycobacterial antigens throughout the course of treatment of 52 tuberculosis patients. U.S. - Jaman Cooperative Medical Panel for the Study of Tuberculosis. Pg. 1-30. Denver Colorado, October 1979.

Kaplan MH, Armstrong D, Pinsky C: Antibody responses to mycobacterial antigens in patients immunized with BCB for the treatment of neoplastic disease. Cancer 46:2195-2202, 1980.

Kaplan MH, Chase MW: Antibodies to mycobacterium in human tuberculosis, I. Development of antibodies before and after antimocrobial therapy. J Infect Dis 142:825-834, 1980.

Kaplan MH, Chase MW: Antibodies to mycobacterium in human tuberculosis II. Responses to nine defined mycobacterial antigens given evidence for an antibody common to tuberculosis and lepromatous leprosy. J Infect Dis 142:835-843, 1980.

Tenenbaum MJ, Kaplan MH: Antibiotic combinations. Med Clinics of North America 66;(1):17-24, 1982.

Kaplan MH, Tenenbaum MJ: Staphylococcus aureus: Cellular biology and clinical application. Amer J Med 72: 248-258, 1982.

Annunziato D, Kaplan MH, Hall WW, Ichinose H, Lin JH, Balsam D, Palladino VS: Atypical measles syndrome: The pathological and serologic findings. Pediatrics 70:203-209, 1982.

Gombert ME, Goldstein EJC, Goldstein MD, Benach JL, Tenenbaum MJ, Grunwaldt E, Kaplan MH, Eveland LK: Human Babesiosis. JAMA 248:3005-3007, 1982.

Kaplan MH, McPhee J, Klein SW, Haprer R: Coxsackie B infections in infants less than three months of age: A serious childhood illness. Rev of Infect Dis 5: 1019-1031, 1983.

Sun T, Tenenbaum MJ, Greenspan J, Teichberg S, Want RT, Degnan T, Kaplan MH: Morphologic and clinical observations in human Babesia microti infection. J Infect Dis 148 (2):239-248, 1983.

Kaplan MH, Chmel H, Stephens A, Hsieh HC, Tenenbaum MJ, Rothenberg IR, Joachim GR: Humoral reactions in human endocarditis due to Streptococcus bovis: Evidence for a common S.bovis antigen. J Infect Dis 148 (2):226-274, 1983.

Tenenbaum MJ, Kaplan MH: Infective endocarditis in the elderly. Geriatrics 39; 3:121-127, 1984.

Moore M, Kaplan MH, McPhee J, Bregman DJ, Klein SW: Epidemiologic, clinical and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-1979. Public Health Reports 99; 5:515-522, 1984.

Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan MH, et al: Frequent detection and isolation of cytopathic retroviruses (HTLV III) from patients with AIDS and at risk for AIDS. Science 224:500-502, 1984.

Fung JC, Kaplan MH, Ksieh HC, Stephens A, Tyburski MB, Tenenbaum MJ: Two coagulase-variant forms of Staphylococcus aureus isolated from blood cultures. J Clin Microbial (Bacteriology) 20;1:115-117, 1984.

Kalb R, Kaplan MH, Tenenbaum MJ, Joachim GR, Samuels S: Cutaneous infarction at dog bite wounds associated with fulminant DF-2 septicemia. Amer J Med 78:687-690, 1985.

Swenson PD & Kaplan MH: Rapid detection of cytomegalovirus in cell culture by indirect immunoperoxidase staining with monoclonal antibody to an early nuclear antigen. J Clin Microbial 21 (5):669-673, 1985.

Pahwa S, Sia C, Harper R, Kaplan MH, & Pahwa R: T lymphocyte sub populations in high-risk infants: Influence of age and blood transfusions. Pediatrics 76:914-917, 1985.

Kalb R, Kaplan MH, Grossman M: Cutaneous Nocardiosis, Case Reports & Review. J Amer Acad Derm 13,1:125-133, 1985.

Fung JC, Clogston A, Swenson PH, Kaplan MH: Serologic diagnosis of toxoplasmosis with emphasis on the detection of toxoplasma-specific immunoglobulin M antibodies. Amer J Clin Pathol 83,2:196-199, 1985.

Berger BW, Kaplan MH, Rothenberg IR & Barbour A: The isolation and characterization of the Lyme Disease spirochete from the skin of patients with Erythema chronicum migrans. J Amer Acad Derm 14 (3):444-449, 1985.

Kaplan MH, Pahwa S, Popovic M, Sarngadharan MG, Gallo RC: The classifications of HTLV III infection in a suburban community. Cancer Research 45:4655s-4658s, 1985.

Pahwa S, Fikrig S, Kaplan MH, Kahn E, & Pahwa R: Expressions of HTLV III infection in a pediatric population. In AIDS-Associated Syndromes, Ed. S. Gupta, Adv Exp Med 187:45-51, 1985.

Swenson PD, Kaplan MH: Rapid detection of respiratory syncytial virus in nasopharyngeal aspirates by a commercial enzyme immunoassay. Clin Microbial 23:485-488, 1986.

Pahwa S, Kaplan MH, Fikrig S, Pahwa R, Sarnagadharan MG, Popovic M, Gallo RC: Spectrum of human T-cell lymphotropic III in Children:Recognition of symptomatic, asymptomatic and seronegative patients. J Amer Med Assoc 255 (17):2299-2305, 1986.

Duffy L, Daum F, Kahn E, Teichberg S, Pahwa R, Fagin J, Fisher S, Kenigsberg K, Kaplan MH, Pahwa S: Hepatitis in children with AIDS: Histopathologic and immunocytologic features. Gastro. 9:173-181, 1986.

Sun T, Greenspan J, Tenenbaum MJ, Farmer P, Jones T, Kaplan MH, Peacock J: Diagnosis of cerebral taxoplasmosis using fluorescein-labeled antitoxoplasma monoclonal antibodies. Amer J Surg Pathol 10(5):212-216, 1986.

Sussman JI, Baron EJ, Tenenbaum MJ, Kaplan MH, Greenspan J, Facklman RR, Tyburski MB, Goldman MA, Kanzer BF, Pizzarello RA: Viridans Streptococcal Endocarditis: Clinical microbiologic and echocardiographic correlations. J Infect Dis 154: (4):597-603, 1986.

Sadick N, Kaplan MH, Pahwa Sg, Sarngadharan MG: Unusual features of scabies complicating HTLV III infection. J Amer Acad Dermatol 15 (3):482-486, 1986.

Gartner S, Markovitz P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M: The role of mononuclear phagocytes in HTLV III/LAV infection. Science 215:219, 1986.

Harper MR, Kaplan MH, Marselle BA, Pahwa S, Chayt KT, Sarngadharan MG, Wong-Stall F, Gallo RD: concomitant infection of HTLV I and HTLV III in a patient with T8 supressor cell proliferative disease. N Engl J Med 315 (17):1073-1078, 1986.

Bakshi SS, Miller TC, Kaplan MH, Hammerschlag MR, Prince A, Gershon AA: Failure of varicella-zoster immunoglobulin in modification of severe congenital varicella. Ped Infect Dis 5 (6):699-702, 1986.

Sussman JI, Baron EJ, Goldberg SM, Kaplan MH, Pizzarello R: Clinical manifestations and therapy of lactobacillus endocarditis: Report of a case and review of the literature. R Infect Dis 8 (5):771-776, 1986.

Scimeca PG, Weinblatt ME, Schonfeld G, Kaplan MH, Kochen JH: Babesiosis in two infants from Eastern Long Island, New York. Amer J Dis Child 140:971, 1986.

Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan MH, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo RC: Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601, 1986.

Fisher M, Swenson P, Lanzone T, Kaplan MH: Chlamydia trachomatis in suburban adolescents. Am J Dis Child 140:294-295, 1986.

Kaplan MH, Chmel H, Ksieh HC, Stephens A, Brinski V: Importance of Exfoliatin Toxin A Production by Staphylococcus aureus Strains Isolated from Clustered Epidemics of Neonatal Pustulosis. J Clin Micro 23 (1):83-91, 1986.

Louria DB, Lavenhar MA, Kaminski T, Buse M, Kaplan MH: Staphylococcal Infections in Aging Mice. J of Gerontology 41 (6):718-722, 1986.

Kaplan MH, Susin M, Pahwa S, Fetten J, Allen SL, Lichtman S, Sarngadharan MG, Gallo RC: Neoplastic complications of HTLV III infection: Lymphomas and solid tumors. Amer J Med 82(3):389-396, 1987.

Kaplan MH, Sadick N, McNutt NS, Meltzer M, Sarngadharan MG, Pahwa S. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Amer Acad Dermatol 16 (3):485-506, 1987.

Schiff MJ, Kaplan MH. Rothia dentocariosa pneumonia in an immunocompromised patient. Lung 165:279-282, 1987.

Kaplan MH. The AIDS epidemic and the drug substance abuse patient. J. Substance Abuse Treatment 4:127-136, 1987.

Swenson PD, Kaplan MH. Rapid detection of influenza virus in cell culture by indirect immunoperoxidase staining with type-specific monoclonal antibodies. Diagn. Microbial. Infect Dis 7:265-268, 1987.

Farber BF, Kaplan MH. The AIDS epidemic: Neglected Issues. J. Infect Dis. 155:1097-1099, 1987.

Swenson PD, Kaplan MH. Comparison of two rapid culture methods for detection of cytomegalovirus in clinical specimens. J. Clin. Micro. 25:2445-2446, 1987.

Sadick NS, Swenson PD, Kaufman RL, Kaplan MH. Comparison of detection of varicella-zoster virus by the Tzanck smear, direct immunofluorescence with a monoclonal antibody and virus isolation. J. Am. Acad. Dermatology 17:64-69, 1987.

Murray HW, Scavuzzo D, Jacobs JL, Kaplan MH, Libby DM, Schindler J, Roberts RB. In vitro and in vivo activation of human mononuclear phagocytes by interferon-g. J. Immunol 138:2457-2462, 1987.

Brown NA, Sumaya CV, Liu CR, Ench Y, Kovacs A, Coronesi M, Kaplan MH. Fall in Human herpesvirus 6 seropositivity with age. Lancet II:396, 1988.

Niederman JC, Liu CR, Kaplan MH, Brown NA. Clinical and serologic features associated with evidence of human herpesvirus-6 infection in three adults. Lancet. 2:817-819, 1988.

Ablashi DV, Josephs SF, Buchbinder A, Hellman S, Nakanura T, Llana T, Lusso P, Kaplan MH, et all: Human B-lymphotropic virus (human herpesvirus-6). J Virological Methods 21:29-48, 1988.

Salahuddin SZ, Nakanura S, Biberfeld P, Kaplan MH, Markham PD, Larsson L, Gallo RC: Angiogenic properties of Kaposi’s sarcoma-derived cells after long-term culture in vitro. Science 242:430-433, 1988.

Lim W, Kahn E, Gupta A, Slade H, Fagin J, Kaplan MH, Daum F, Pahwa S: Treatment of cytomegalovirus enterocolitis with ganciclovir in an infant with acquired immunodeficiency syndrome. Pediatr Infect Dis 7:354-357, 1988.

Pahwa S, Biron K, Lim W, Swenson P, Kaplan MH, Sadick N, Pahwa R: Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. JAMA 260 (19):2879-2882, 1988.

Schiff M, Kaplan MH, Farber BF. AIDS: A late complication of cardio-thoracic surgery. J. of Thoracic Cardiovascular Surgery 97:126-129, 1989.

Kaplan MH, Sadick N, Wieder J, Farber BF, Neidt GW: Antipsoriatic effects of zidovudine in human immunodeficiency virus-associated psoriasis. J Amer Acad Dermatology 20 (1):76-82, 1989.

Kovner R, Perceman E, Lazar W, Hainline B, Kaplan MH, Lesser M, Beresford HR: Relation of personality and attentional factors to cognitive deficits in HIV infected subjects. Archives of Neurology 46 (3):274-277, 1989.

Kaplan MH. Central Nervous system infections. Current Opinion in Infectious Diseases 2:287-294, 1989.

Kaplan MH. Interactions of Epstein-Barr virus with human retroviruses. In Epstein-Barr Virus and Human Disease. Humana Press Inc., pgs. 473-480, 1989.

Contact this candidate